Catalyst Pharmaceutical Partners (CPRX)

[SmurfVA]

CPRX ($2.13) Whoa whoa this was unexpected.. Catalyst Pharmaceutical Partners, Inc. Announces Commencement of Public Offering of Common Stock

CORAL GABLES, Fla., April 2, 2014 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (CPRX) announced today that it intends to offer shares of its common stock in a public offering. Catalyst also expects to grant the underwriters a 30-day option to purchase additional shares of its common stock to cover over-allotments, if any. Catalyst plans to use the net proceeds from the offering (i) for the continuing development of Firdapse(TM) for the treatment of Lambert-Eaton Myasthenic Syndrome, or LEMS, (ii) for pre-commercialization activities relating to Firdapse(TM), (iii) for the continuing development of CPP-115, and (iv) for general corporate purposes.

Piper Jaffray & Co. is acting as the sole book-running manager.

This offering will be made pursuant to a prospectus supplement to Catalyst's prospectus, dated March 19, 2014, which was filed as a part of Catalyst's effective $100 million shelf registration statement. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.

Copies of the preliminary prospectus supplement and the accompanying prospectus relating to these securities may be obtained by contacting Piper Jaffray & Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, MN 55402, or by telephone at 800-747-3924 or by e-mail at [e-mail].

ref. http://finance.yahoo.com/news/catalyst-pharmaceutical-partners-inc-announces-200424616.html